Registry for tracking acute heart attacks

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Registry of Acute Myocardial Infarction (RAMI) collects and processes standardized information on confirmed and suspected cases of acute myocardial infarction (AMI) using WHO-recommended diagnostic criteria. Data is gathered from all medical institutions in Tomsk, Russia, and recorded in a specialized database designed for statistical analysis and reporting. Each case is categorized based on diagnostic criteria after 28 days from the onset of symptoms, allowing for comprehensive epidemiological analysis of AMI in the population. The study aims to monitor morbidity, mortality, and lethality associated with AMI.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age of at least 20 years;
* being a resident or visitor of the city of Tomsk at a time of AMI onset;
* the presence of definite AMI or possible AMI. Definite AMI is diagnosed in the presence of characteristic ECG changes, regardless of clinical course and changes in serum enzymes; or the presence of typical pain syndrome, "ambiguous" ECG changes, and definite increase in the activity of serum enzymes i.e. exceeding the upper limit of normal by 25% or more; or macroscopically detected focus of myocardial necrosis and (or) fresh thrombotic occlusion of the coronary artery. Possible AMI is registered in the presence of typical pain syndrome with ambiguous ECG changes and an ambiguous (up to 25%) increase in the levels of serum enzymes; or the presence of obstruction in the lumen of at least one coronary artery by at least 50% and (or) the presence of a post-infarction scar in the myocardium with a diameter of 0.5 cm or more, while simultaneously excluding a non-coronary cause of death. In case of atypical clinical picture, ambiguous or absent ECG changes, when the enzyme levels are not determined or their activity does not reach a pathological level, AMI case is considered unconfirmed. In the absence of data that could confirm or not confirm AMI, the case is interpreted as "insufficient data"

Exclusion Criteria:

* none.

Where it's running

• Tomsk National Research Medical Center, Russian Academy of Sciences
  Tomsk, Russia Recruiting

Study contacts

• Study coordinator: Nina D. Anfinogenova, PhD
• Email: cardio.intl@gmail.com
• Phone: +73822554111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-term follow-up for young women after a heart attack

  This follow-up will see if tracking health outcomes, quality of life, and mental health over time helps understand risks for women who had a heart attack before age 50.

  Recruiting French Cardiology Society · Paris · NCT07181317

• Rapid high-sensitivity Troponin I testing in ambulance care

  This tests whether a rapid high-sensitivity troponin I blood test used by ambulance crews helps identify heart attacks earlier in people with chest pain or suspected myocardial infarction.

  Recruiting Karolinska Institutet · Stockholm, Årsta · NCT07008391

• Understanding genetic factors in young adults with heart attacks

  This study is trying to find out how genetics might play a role in heart attacks for young adults under 60 who don’t have typical heart disease risk factors.

  Recruiting National Heart Centre Singapore · Singapore · NCT06698341

• Effect of intravenous iron treatment on heart health and quality of life in patients with recent heart attacks and iron deficiency

  This study is testing if giving intravenous iron to people with recent heart attacks and low iron levels can improve their heart health and quality of life.

  Recruiting at 31 sites Phase 4 Wroclaw Medical University · Bydgoszcz, Kuyavian-Pomeranian Voivodeship and 42 other locations · NCT05759078

• Using eplerenone to treat heart injury in patients with small vessel disease

  This study is testing if the medication eplerenone can help reduce heart damage and improve recovery for patients with heart injuries caused by small vessel disease.

  Recruiting at 2 sites Phase 2 NHS National Waiting Times Centre Board · East Kilbride, Lanarkshire and 1 other locations · NCT05198791

• Evaluating revascularization strategies for patients with NSTEMI and multivessel coronary artery disease

  This study is testing whether treating all blocked heart arteries right away or doing it in stages is better for people with NSTEMI and multiple blocked arteries.

  Recruiting Chonnam National University Hospital · Gwangju · NCT04968808

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.